DUPONT CAPITAL MANAGEMENT CORP - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 167 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
DUPONT CAPITAL MANAGEMENT CORP ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$183,000
+4.0%
61,175
-8.1%
0.01%
+16.7%
Q4 2021$176,000
-71.0%
66,586
-60.2%
0.01%
-68.4%
Q3 2021$607,000
+3.8%
167,227
+24.1%
0.02%
+35.7%
Q2 2021$585,000
+26.9%
134,7240.0%0.01%
+27.3%
Q1 2021$461,000
-18.8%
134,724
-17.0%
0.01%
-8.3%
Q4 2020$568,000
+35.6%
162,353
-6.9%
0.01%
+33.3%
Q3 2020$419,000
+87.1%
174,470
+42.7%
0.01%
+80.0%
Q2 2020$224,000122,2520.01%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,847,087$4,119,0003.26%
Sio Capital Management, LLC 1,333,696$2,974,0001.52%
Boxer Capital, LLC 700,000$1,561,0001.38%
Palo Alto Investors LP 5,386,534$12,012,0000.91%
ACUTA CAPITAL PARTNERS, LLC 747,748$1,667,0000.80%
SENZAR ASSET MANAGEMENT, LLC 1,443,003$3,217,897,0000.70%
Ghost Tree Capital, LLC 800,000$1,784,0000.52%
NEA Management Company, LLC 3,243,150$7,232,0000.38%
Rhenman & Partners Asset Management AB 850,000$1,896,0000.34%
Rock Springs Capital Management LP 1,750,000$3,903,0000.29%
View complete list of RIGEL PHARMACEUTICALS INC shareholders